UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042682
Receipt number R000048688
Scientific Title Prospective study to develop optimal range of lymph node dissection for duodenal tumor
Date of disclosure of the study information 2020/12/21
Last modified on 2021/12/20 12:52:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study to develop optimal range of lymph node dissection for duodenal tumor

Acronym

Prospective study to develop optimal range of lymph node dissection for duodenal tumor

Scientific Title

Prospective study to develop optimal range of lymph node dissection for duodenal tumor

Scientific Title:Acronym

Prospective study to develop optimal range of lymph node dissection for duodenal tumor

Region

Japan


Condition

Condition

duodenal tumor

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To develop optimal range of lymph node dissection for duodenal tumor

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Range of lymphatic flow visualized by ICG during duodenectomy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Local injection of ICG to duodenal submucosa

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Diagnosed with deep submucosa primary non-ampullary duodenal tumor in preoperative radiography
2. Tumor limited to duodenum, no transmission to other organs
3. No specific limitations in terms of sample cells in biopsy
4. Implementation of surgery for duodenal tumor
5. 20 years old or older
6. Written informed consent to this study

Key exclusion criteria

1. Pregnant with drug allergy history to (iodine, ICG) or asthma history
2. Tumor is at duodenal papilla
3. Indications for endoscopic treatment where the tumor is found remaining in the mucosa by preoperative radiography
4. Evaluated not to be appropriate for inclusion by attending physician
5. When the subject refuses to participate in this study after enrolling

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hirofumi
Middle name
Last name Kawakubo

Organization

Keio University School of Medicine

Division name

Department of Surgery

Zip code

1608582

Address

35 Shinanomachi, Shunjuku-ku, Tokyo

TEL

0333531211

Email

hkawakubo@keio.jp


Public contact

Name of contact person

1st name Satoru
Middle name
Last name Matsuda

Organization

Keio University School of Medicine

Division name

Department of Surgery

Zip code

1608582

Address

35 Shinanomachi, Shunjuku-ku, Tokyo

TEL

0333531211

Homepage URL


Email

s.matsuda.a8@keio.jp


Sponsor or person

Institute

Department of Surgery, Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery, Keio University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

35 Shinanomachi, Shunjuku-ku, Tokyo

Tel

0333531211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 11 Month 04 Day

Date of IRB

2020 Year 12 Month 21 Day

Anticipated trial start date

2020 Year 12 Month 25 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 07 Day

Last modified on

2021 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048688


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name